Evidence map›Paper›PMID 37692230›Full record

ArticleACS omega2023

Synthesis, Structural Investigations, DNA/BSA Interactions, Molecular Docking Studies, and Anticancer Activity of a New 1,4-Disubstituted 1,2,3-Triazole Derivative.

Tolga Göktürk, Esin Sakallı Çetin, Tuncer Hökelek, Hanife Pekel, Özge Şensoy, Ebru Nur Aksu, Ramazan Güp

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tolga GöktürkDepartment of Chemistry, Muğla Sıtkı Koçman University, 48000 Muğla, Türkiye.ORCID https://orcid.org/0000-0002-7234-8079
Esin Sakallı ÇetinDepartment of Medical Biology, Muğla Sıtkı Koçman University, 48000 Muğla, Türkiye.ORCID https://orcid.org/0000-0002-9715-1424
Tuncer HökelekDepartment of Physics, Hacettepe University, 06800 Ankara, Türkiye.ORCID https://orcid.org/0000-0002-8602-4382
Hanife PekelDepartment of Pharmacy Services, Vocational School of Health Services, Istanbul Medipol University, 34810 Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-4861-1770
Özge ŞensoyDepartment of Computer Engineering, Istanbul Medipol University, 34000 Istanbul, Türkiye.
Ebru Nur AksuDepartment of Medical Biology, Muğla Sıtkı Koçman University, 48000 Muğla, Türkiye.
Ramazan GüpDepartment of Chemistry, Muğla Sıtkı Koçman University, 48000 Muğla, Türkiye.
Muğla University · TRIstanbul Medipol University · TRHacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report herein a new 1,2,3-triazole derivative, namely, 4-((1-(3,4-dichlorophenyl)-1

Identifiers

PMID37692230
PMCPMC10483525
OpenAlexW4386168657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.